Literature DB >> 15894663

Endometrial cancer incidence trends in Europe: underlying determinants and prospects for prevention.

Freddie Bray1, Isabel Dos Santos Silva, Henrik Moller, Elisabete Weiderpass.   

Abstract

More than one in 20 female cancers in Europe are of the endometrium. Surveillance of incidence rates is imperative given the rapidly changing profile in the prevalence and distribution of the underlying determinants. This study presents an analysis of observed and age-period-cohort-modeled trends in 13 European countries. There were increasing trends among postmenopausal women in many Northern and Western countries. Denmark and possibly France and Switzerland were exceptions, with decreasing trends in postmenopausal women. In premenopausal and perimenopausal women, declines were observed in Northern and Western Europe, most evidently in Denmark, Sweden, and the United Kingdom, affecting consecutive generations born after 1925. These contrast with the increasing trends regardless of menopausal age in some Southern and Eastern European countries, particularly Slovakia and Slovenia. These observations provide evidence of changes in several established risk factors over time and have implications for possible primary prevention strategies. In postmenopausal women, changes in reproductive behavior and prevalence of overweight and obesity may partially account for the observed increases, as well as hormone replacement therapy use in certain countries. Combined oral contraceptive use may be responsible for the declines observed among women aged <55 years. Whereas there are some prospects for chemoprevention in premenopausal women as oral contraceptive use becomes more widespread in Europe, increases in obesity and decreases in fertility imply that endometrial cancer in postmenopausal women will become a more substantial public health problem in the future.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15894663     DOI: 10.1158/1055-9965.EPI-04-0871

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  28 in total

1.  Advances in magnetic resonance imaging of endometrial cancer.

Authors:  Evis Sala; Andrea Rockall; Rahel A Kubik-Huch
Journal:  Eur Radiol       Date:  2010-11-27       Impact factor: 5.315

2.  Poor prognosis of uterine serous carcinoma compared with grade 3 endometrioid carcinoma in early stage patients.

Authors:  Ji Young Park; Joo-Hyun Nam; Young-Tak Kim; Yong-Man Kim; Jong-Hyeok Kim; Dae-Yeon Kim; Insuk Sohn; Shin-Wha Lee; Chang Ohk Sung; Kyu-Rae Kim
Journal:  Virchows Arch       Date:  2013-02-17       Impact factor: 4.064

3.  Preoperative work-up for definition of lymph node risk involvement in early stage endometrial cancer: 5-year follow-up.

Authors:  Pietro Cignini; Salvatore Giovanni Vitale; Antonio Simone Laganà; Antonio Biondi; Valentina Lucia La Rosa; Giuseppe Cutillo
Journal:  Updates Surg       Date:  2017-01-20

Review 4.  Modern management of rare brain metastases in adults.

Authors:  Matthias J Krammer; Andre Tomasino; David B Schul; Sabrina T Astner; Michael P Meier; Christianto B Lumenta
Journal:  J Neurooncol       Date:  2011-06-21       Impact factor: 4.130

5.  Validation of REM score to predict endometrial cancer in patients with ultrasound endometrial abnormalities: results of a new independent dataset.

Authors:  Francesco Plotti; Stella Capriglione; Corrado Terranova; Roberto Montera; Giuseppe Scaletta; Salvatore Lopez; Daniela Luvero; Antonelli Gianina; Alessia Aloisi; Pierluigi Benedetti Panici; Roberto Angioli
Journal:  Med Oncol       Date:  2017-04-07       Impact factor: 3.064

6.  Use of mutation profiles to refine the classification of endometrial carcinomas.

Authors:  Melissa K McConechy; Jiarui Ding; Maggie Cu Cheang; Kimberly Wiegand; Janine Senz; Alicia Tone; Winnie Yang; Leah Prentice; Kane Tse; Thomas Zeng; Helen McDonald; Amy P Schmidt; David G Mutch; Jessica N McAlpine; Martin Hirst; Sohrab P Shah; Cheng-Han Lee; Paul J Goodfellow; C Blake Gilks; David G Huntsman
Journal:  J Pathol       Date:  2012-07-18       Impact factor: 7.996

7.  Diabetes mellitus and risk of endometrial cancer: a meta-analysis.

Authors:  E Friberg; N Orsini; C S Mantzoros; A Wolk
Journal:  Diabetologia       Date:  2007-05-03       Impact factor: 10.122

8.  Evaluation of the accuracy of preoperative MRI in measuring myometrial infiltration in endometrial carcinoma.

Authors:  Katalin Horváth; Imre Pete; Ildikó Vereczkey; Anna Dudnyikova; Mária Gődény
Journal:  Pathol Oncol Res       Date:  2013-12-01       Impact factor: 3.201

9.  Lithium chloride treatment induces epithelial cell proliferation in xenografted human endometrium.

Authors:  Alex J Polotsky; Liyin Zhu; Nanette Santoro; Jeffrey W Pollard
Journal:  Hum Reprod       Date:  2009-04-29       Impact factor: 6.918

10.  The role of novel biomarker HE4 in endometrial cancer: a case control prospective study.

Authors:  Roberto Angioli; Francesco Plotti; Stella Capriglione; Roberto Montera; Patrizio Damiani; Roberto Ricciardi; Alessia Aloisi; Daniela Luvero; Ester Valentina Cafà; Nella Dugo; Michela Angelucci; Pierluigi Benedetti-Panici
Journal:  Tumour Biol       Date:  2012-11-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.